drugset / Trial / NCT06419660

A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood

NCT06419660

Phase 1 Completed 15 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of this trial is to investigate the effect of the proton pump inhibitor esomeprazole on the pharmacokinetics of BI 3000202 in plasma.

Timeline

Start
2024-05-22
Primary completion
2024-07-08
Completion
2024-07-08

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 300202 Unknown
Subject Esomeprazole Small molecule

Indications

No indication recorded.